Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Date:4/25/2013

esMed to defer processing conversions between its common stock and CDI registers from May 15, 2013 through May 21, 2013, inclusive. 

Michael "Mick" Farrell, chief executive officer, commented, "In the third quarter of fiscal 2013 we showed strong year-over-year growth on both top and bottom lines. Revenue in the Americas increased by 13%, to $215.2 million over the prior year's quarter. Revenue outside the Americas was $168.4 million, an increase of 6% (also a 6% increase on a constant currency basis) over the prior year's quarter.  Operating profit for the March quarter was $96.1 million, cash flow from operations was $107.0 million, while gross margin was 62.4%, all demonstrating excellent operating performance. During the quarter, we also repurchased 1.5 million shares, at a cost of $67.3 million, as part of our ongoing capital management program.

"We are confident we have the right product pipeline for the future.  We will be launching an important and exciting new mask this quarter, and expect to launch an additional mask later this calendar year.  Finally, we are pleased to announce the launch of a new product today: VPAP™ COPD.  The VPAP COPD is the first and only home bilevel cleared by the FDA specifically for the treatment of chronic obstructive pulmonary disease (COPD), giving patients and payors a weapon in the fight to keep COPD patients out of the hospital.  We have also developed new ClimateLineMAX™Oxy tubing that connects between the humidifier and mask, with an oxygen line input next to the VPAP COPD device, enhancing comfort and ease of use.  Both of these products will improve the lives of patients suffering from this debilitating and costly chronic disease." 

About ResM
'/>"/>

SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
2. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
3. ResMed Takes Action to Enforce Patents
4. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
5. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
8. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
9. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
10. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
11. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014 Aileron Therapeutics, Inc. ... Global Markets Direct,s, ,Aileron Therapeutics, Inc. - ... of the Aileron Therapeutics, Inc.,s pharmaceutical research and ... on the current therapeutic developmental pipeline of Aileron ... stages, therapeutics assessment by drug target, mechanism of ...
(Date:9/30/2014)... Sept. 30, 2014  Decision Resources Group finds that the ... , China , India ... a strong rate through 2023. Dental implant procedure volumes will grow ... awareness rises. Other key findings from Decision Resources Group,s ... market: , Dental implant penetration: Penetration of dental ...
(Date:9/30/2014)... , September 30, 2014 ... research report the "Glycobiology/Glycomics Market by Product [Enzymes ... MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) ... to 2019", published by MarketsandMarkets, provides a ... challenges, opportunities, current market trends, and strategies ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4
... BALTIMORE, April 24, 2012   The University of Maryland ... Vice President of Research and Development at MedImmune ... the UM Health Sciences Research Park Corporation (RPC) ... ) "The BioPark leadership team is ...
... Simcere Pharmaceutical Group (NYSE: SCR ), a ... marketing of branded generic and proprietary pharmaceuticals in China, ... results for the first quarter ended March 31, 2012 ... in the United States. Simcere,s management will host an ...
Cached Medicine Technology:University of Maryland BioPark Announces MedImmune's Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park 2University of Maryland BioPark Announces MedImmune's Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park 3Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012 2
(Date:10/1/2014)... of scientists has shown that more than 80 per ... drugs. , The study found that medicines called ,JAK ... genetic mutation that is present in more than 80 ... currently used, or are in clinical trials, for diseases ... , Bowel cancer is the second-most common cancer in ...
(Date:10/1/2014)... 1, 2014 Patients with increased inflammation, including ... greatly increased risk of depression. For example, a ... hepatitis C virus infection causes depression in approximately ... more commonly known as fish oil, have a ... risk of heart disease and reducing triglyceride levels. ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining ... , Senior citizens can purchase a joint life insurance ... A joint policy is cheaper, but will only pay ... Life insurance can be used to cover important funeral ... online, as the application process is simple and straightforward. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 First Warning ... abnormal circadian cellular changes throughout the body, announced the ... to better address the company’s breadth of upcoming product ... breast cancer screening technology. , “Our initial focus will ... system which detects abnormal circadian cellular changes over time,” ...
(Date:10/1/2014)... 2014 Join the more than 80 golfers ... Center’s first ever charity golf tournament to benefit Project HEAL, ... disorders who cannot afford treatment. The tournament will be held ... Mo. , The day-long event starts with 10:30 a.m. ... award dinner will begin at 5 p.m. and will include ...
Breaking Medicine News(10 mins):Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3
... new drugs is a highly costly and time-consuming process. Of ... or have unwanted side effects. Now a research team led ... tiny molecular "binder" that has the potential to change this ... journal Angewandte Chemie , presents the concept of a ...
... general wards are twice as likely to die as those ... treatment of the condition, published online in the journal ... comes to appropriate investigations and treatment, the findings suggest, although ... accounted for more than a quarter of a million hospital ...
... and patient embarrassment may prevent dermatologists, internists and ... to a report in the January issue of ... JAMA/Archives journals. However, dermatologists are significantly more likely ... screenings. Skin cancer is the most frequently ...
... , MONDAY, Jan. 17 (HealthDay News) -- Patients at ... can detect the deadly skin cancer at an early stage, ... prevents some people from having a doctor examine their skin ... Archives of Dermatology . People at high risk ...
... First Nations (North American Indian) babies are linked to a ... 4 weeks to 1 year of age), according to a ... Journal ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100837.pdf . High ... being born above the 90th percentile relative to a fetal ...
... News) -- Cigarettes start to destroy a smoker,s DNA ... the habit causes immediate genetic damage and quickly raises ... here should serve as a stark warning to those ... author Stephen S. Hecht, from the Masonic Cancer Center ...
Cached Medicine News:Health News:Breakthrough for more efficient drug development 2Health News:Heart failure patients twice as likely to die if admitted to general wards 2Health News:Clinicians cite time, patient embarrassment as barriers to performing skin cancer exams 2Health News:Thorough Exams a Must for Those at High Risk of Skin Cancer 2Health News:Thorough Exams a Must for Those at High Risk of Skin Cancer 3Health News:High birth weight in First Nations babies linked to a higher risk of postneonatal death 2Health News:Smoking Damages DNA Within Minutes, Research Shows 2
Suture Cutters, Straight...
Suture scissor...
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
The Small Oval Cannula System is designed to be the smallest oval cannula system currently available, and is utilized with the Caspari Suture Punch System. Disposable seals are available with this sy...
Medicine Products: